Literature DB >> 6418552

Regulation of muscarinic agonist binding by cations and guanine nucleotides.

E C Hulme, C P Berrie, N J Birdsall, M Jameson, J M Stockton.   

Abstract

EDTA treatment of membrane preparations from rat brain and myocardium reduced the relative proportion of superhigh and high affinity binding sites for muscarinic agonists by up to 60%. This effect was partially or completely reversed by millimolar concentrations of Mg2+ or Mn2+. A number of multivalent metal cations gave qualitatively similar effects, yielding stimulation of agonist binding at low concentrations but inhibition at higher concentrations. The divalent cation-linked subpopulation of muscarinic agonist binding sites identified in this study appears to be the primary target for guanine nucleotide inhibition.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6418552     DOI: 10.1016/0014-2999(83)90442-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  15 in total

1.  Modulation of the structure-binding relationships of antagonists for muscarinic acetylcholine receptor subtypes.

Authors:  E K Pedder; P Eveleigh; D Poyner; E C Hulme; N J Birdsall
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

2.  Relative affinities of drugs acting at cholinoceptors in displacing agonist and antagonist radioligands: the NMS/Oxo-M ratio as an index of efficacy at cortical muscarinic receptors.

Authors:  S B Freedman; E A Harley; L L Iversen
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

3.  Proceedings of the British Pharmacological Society. London, 17th-19th December, 1984. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1985-03       Impact factor: 8.739

4.  Prevention of guanine nucleotide-induced reductions in muscarinic agonist binding to rabbit ileal submucosal membranes by lidamidine and tetracaine.

Authors:  D Bleakman; R J Naftalin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-04       Impact factor: 3.000

5.  Solubilization and characterization of high and low affinity pirenzepine binding sites from rat cerebral cortex.

Authors:  C P Berrie; N J Birdsall; E C Hulme; M Keen; J M Stockton
Journal:  Br J Pharmacol       Date:  1985-07       Impact factor: 8.739

6.  Age-dependent decrease in the affinity of muscarinic M1 receptors in neocortex of rhesus monkeys.

Authors:  M G Vannucchi; P S Goldman-Rakic
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

7.  Membrane phospholipid polar heads influence the coupling of M2 muscarinic receptors to G proteins.

Authors:  J P Gies; C Bertrand; Y Landry
Journal:  Neurochem Res       Date:  1988-08       Impact factor: 3.996

8.  Binding studies with [3H]cis-methyldioxolane in different tissues. Under certain conditions [3H]cis-methyldioxolane labels preferentially but not exclusively agonist high affinity states of muscarinic M2 receptors.

Authors:  A Closse; H Bittiger; D Langenegger; A Wanner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-04       Impact factor: 3.000

9.  An [3H]oxotremorine binding method reveals regulatory changes by guanine nucleotides in cholinergic muscarinic receptors of cerebral cortex.

Authors:  S Raskovsky; J S Aguilar; D Jerusalinsky; E De Robertis
Journal:  Neurochem Res       Date:  1988-06       Impact factor: 3.996

10.  Pharmacological characterization of a receptor for calcitonin gene-related peptide on rat, L6 myocytes.

Authors:  D R Poyner; D P Andrew; D Brown; C Bose; M R Hanley
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.